QCOM
45
2
KIM
50
-3
ZBH
42
-2
COP
47
3
XYL
33
6
PNW
53
-3
TXT
82
4
DUK
52
-5
KLAC
72
2
HSY
43
2
CNP
49
-6
APH
56
7
ADT
50
2
BWA
53
-7
MAR
71
3
V
52
2
OXY
40
2
EMC
47
11
MTB
73
4
UNP
38
2
QCOM
45
2
KIM
50
-3
ZBH
42
-2
COP
47
3
XYL
33
6
PNW
53
-3
TXT
82
4
DUK
52
-5
KLAC
72
2
HSY
43
2
CNP
49
-6
APH
56
7
ADT
50
2
BWA
53
-7
MAR
71
3
V
52
2
OXY
40
2
EMC
47
11
MTB
73
4
UNP
38
2
Financhill
Back

VanEck Digital Transformation ETF Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison

Buy
51

DAPP
VanEck Digital Transformation ETF

Last Price:
$17.85
Seasonality Move:
-3.09%
Buy
54

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:
$61.19
Seasonality Move:
5.52%
Buy
51
VanEck Digital Transformation ETF (DAPP) is a Buy

Is VanEck Digital Transformation ETF a Buy, Sell or Hold?

  • The current VanEck Digital Transformation ETF [DAPP] share price is $17.86. The Score for DAPP is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • DAPP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN) is a Buy

Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DAPP Stock Price Chart

What is VanEck Digital Transformation ETF's stock price today?

  • The VanEck Digital Transformation ETF share price today is $17.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DAPP is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Stock Price Chart

What is BioMarin Pharmaceutical, Inc.'s stock price today?

  • The BioMarin Pharmaceutical, Inc. share price today is $61.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.

DAPP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.79 Sell
Relative Strength Index (14 RSI): 45.18 Sell
Chaikin Money Flow: 942391 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.77 - 19.29) Sell
Bollinger Bands (100): (16.96 - 23.18) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 73.39 Buy
Chaikin Money Flow: 7836963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.19 - 56.01) Buy
Bollinger Bands (100): (52.65 - 57.43) Buy

DAPP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.88 Sell
20-day SMA: 18.3 Sell
50-day SMA: 20.83 Sell
200-day SMA: 16.61 Buy
8-day EMA: 17.66 Buy
20-day EMA: 18.4 Sell
50-day EMA: 19.54 Sell
200-day EMA: 17.83 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.6 Buy
20-day SMA: 54.21 Buy
50-day SMA: 53.61 Buy
200-day SMA: 57.94 Buy
8-day EMA: 54.44 Buy
20-day EMA: 53.99 Buy
50-day EMA: 54.1 Buy
200-day EMA: 58.28 Buy

VanEck Digital Transformation ETF Earnings Growth & DAPP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.68 per share.

VanEck Digital Transformation ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioMarin Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):